Current Assets
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)
Synopsys Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) decreased by 16.5% to $2.42B in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2024
Last reportedQ2 2026May 27, 2026
Metric ID:
cash_and_equivalents_total_inclusiveHistorical Data
4 periods
| Q4 '24 | Q2 '25 | Q4 '25 | Q2 '26 | |
|---|---|---|---|---|
| Value | $3.9B | $14.12B | $2.89B | $2.42B |
| QoQ Change | — | +262.3% | -79.5% | -16.5% |
| YoY Change | — | — | -25.8% | -82.9% |
Range$2.42B – $14.12B
Avg YoY Growth-54.3%
Median YoY Growth-54.3%
Current Streak2 quarters decline
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at Other Companies
Frequently Asked Questions
- What is Synopsys's total cash, cash equivalents, and restricted cash (inclusive)?
- Synopsys (SNPS) reported total cash, cash equivalents, and restricted cash (inclusive) of $2.42B in Q1 2026.